JP2016216487A5 - - Google Patents

Download PDF

Info

Publication number
JP2016216487A5
JP2016216487A5 JP2016137461A JP2016137461A JP2016216487A5 JP 2016216487 A5 JP2016216487 A5 JP 2016216487A5 JP 2016137461 A JP2016137461 A JP 2016137461A JP 2016137461 A JP2016137461 A JP 2016137461A JP 2016216487 A5 JP2016216487 A5 JP 2016216487A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
joint
stem cells
mesenchymal stem
allogeneic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016137461A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016216487A (ja
JP6382262B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016216487A publication Critical patent/JP2016216487A/ja
Publication of JP2016216487A5 publication Critical patent/JP2016216487A5/ja
Application granted granted Critical
Publication of JP6382262B2 publication Critical patent/JP6382262B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2016137461A 2000-04-25 2016-07-12 動物の関節修復のための医薬組成物調製への間葉幹細胞の使用法 Expired - Lifetime JP6382262B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19954900P 2000-04-25 2000-04-25
US60/199,549 2000-04-25
US23610600P 2000-09-28 2000-09-28
US60/236,106 2000-09-28

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015035361A Division JP2015128633A (ja) 2000-04-25 2015-02-25 動物の関節修復のための医薬組成物調製への間葉幹細胞の使用法

Publications (3)

Publication Number Publication Date
JP2016216487A JP2016216487A (ja) 2016-12-22
JP2016216487A5 true JP2016216487A5 (enExample) 2017-04-27
JP6382262B2 JP6382262B2 (ja) 2018-08-29

Family

ID=26894885

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2001577964A Expired - Lifetime JP5090604B2 (ja) 2000-04-25 2001-04-24 動物の関節修復のための医薬組成物調製への間葉幹細胞の使用法
JP2012141003A Expired - Lifetime JP5792686B2 (ja) 2000-04-25 2012-06-22 動物の関節修復のための医薬組成物調製への間葉幹細胞の使用法
JP2015035361A Pending JP2015128633A (ja) 2000-04-25 2015-02-25 動物の関節修復のための医薬組成物調製への間葉幹細胞の使用法
JP2016137461A Expired - Lifetime JP6382262B2 (ja) 2000-04-25 2016-07-12 動物の関節修復のための医薬組成物調製への間葉幹細胞の使用法

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2001577964A Expired - Lifetime JP5090604B2 (ja) 2000-04-25 2001-04-24 動物の関節修復のための医薬組成物調製への間葉幹細胞の使用法
JP2012141003A Expired - Lifetime JP5792686B2 (ja) 2000-04-25 2012-06-22 動物の関節修復のための医薬組成物調製への間葉幹細胞の使用法
JP2015035361A Pending JP2015128633A (ja) 2000-04-25 2015-02-25 動物の関節修復のための医薬組成物調製への間葉幹細胞の使用法

Country Status (10)

Country Link
US (5) US20020005205A1 (enExample)
EP (1) EP1276486B2 (enExample)
JP (4) JP5090604B2 (enExample)
AT (1) ATE489101T1 (enExample)
AU (2) AU2001257236B2 (enExample)
CA (1) CA2405345C (enExample)
DE (1) DE60143517D1 (enExample)
ES (1) ES2353061T5 (enExample)
PT (1) PT1276486E (enExample)
WO (1) WO2001080865A2 (enExample)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60143517D1 (de) * 2000-04-25 2011-01-05 Osiris Therapeutics Inc Wiederherstellung der gelenken mit mesenchymalen stammzellen
DE10139783C1 (de) * 2001-08-14 2003-04-17 Transtissue Technologies Gmbh Zellzusammensetzungen zur Behandlung von Osteoarthrose, sowie Verfahren zu deren Herstellung
US20030109038A1 (en) 2001-12-07 2003-06-12 Thies R. Scott Chondrocyte precursors derived from human embryonic stem cells
AR047712A1 (es) 2002-09-07 2006-02-15 Royal Veterinary College Metodo de tratamiento de una lesion de tejido esqueletico blando natural administrando una composicion de celulas madre mesenquimatosas
EP2450433A3 (en) 2003-10-08 2012-08-08 Vet-Stem Inc Methods of preparing and using stem cell compositions and kits comprising the same
US8012693B2 (en) 2003-12-16 2011-09-06 3M Innovative Properties Company Analysis of chemically crosslinked cellular samples
ES2544689T3 (es) * 2004-03-22 2015-09-02 Mesoblast International Sàrl Células madre mesenquimales y usos de las mismas
AU2015252160A1 (en) * 2004-03-22 2015-11-26 Mesoblast International Sarl Mesenchymal stem cells and uses therefor
WO2005093044A1 (en) * 2004-03-22 2005-10-06 Osiris Therapeutics, Inc. Mesenchymal stem cells and uses therefor
AU2012205269B2 (en) * 2004-03-22 2015-08-27 Mesoblast International Sarl Mesenchymal stem cells and uses therefor
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
US20110177492A1 (en) * 2005-06-16 2011-07-21 3M Innovative Properties Company Method of classifying chemically crosslinked cellular samples using mass spectra
EP1924606A4 (en) 2005-08-25 2010-01-13 Repair Technologies Inc DEVICES, COMPOSITIONS AND METHODS FOR PROTECTING AND REPAIRING CELLS AND TISSUE
GB0600972D0 (en) * 2006-01-18 2006-03-01 Univ Leeds Enrichment of cells
NZ594639A (en) 2006-03-07 2013-04-26 Geeta Shroff Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
US20080260703A1 (en) * 2007-04-23 2008-10-23 Medistem Labortories Treatment of Insulin Resistance and Diabetes
US9095562B2 (en) * 2007-07-05 2015-08-04 Regenerative Sciences, Inc. Methods and compositions for optimized expansion and implantation of mesenchymal stem cells
TWI603736B (zh) * 2007-08-06 2017-11-01 安吉歐公司 活體內產生、修補及/或維持結締組織的方法
ES2704153T3 (es) * 2007-08-06 2019-03-14 Mesoblast Inc Células STRO-1brillantes para su uso en el tratamiento de enfermedades de tejidos conectivos
AU2013203054B2 (en) * 2007-08-06 2017-05-18 Mesoblast, Inc. Methods of generating, repairing and/or maintaining connective tissue in vivo
US20110200642A1 (en) 2007-12-19 2011-08-18 Regenerative Sciences, Llc Compositions and Methods to Promote Implantation and Engrafment of Stem Cells
DK2252290T3 (en) 2008-02-15 2018-03-05 Bone Therapeutics Sa PHARMACEUTICAL COMPOSITION FOR USE FOR TREATMENT AND / OR PREVENTION OF OSTEOARTICULAR DISEASES
EP2090308A1 (en) * 2008-02-15 2009-08-19 Bone Therapeutics Pharmaceutical composition for the treatment or prevention of osteoarticular diseases
AU2009214044B2 (en) * 2008-02-15 2014-08-14 Bone Therapeutics Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
US20110052533A1 (en) 2008-03-14 2011-03-03 Regenerative Sciences, Llc Compositions and Methods for Cartilage Repair
KR101776959B1 (ko) 2008-06-25 2017-09-08 메소블라스트, 아이엔씨. 추간판의 치료 및/또는 재구성
US8343480B2 (en) * 2008-11-14 2013-01-01 Howmedica Osteonics Corp. Administration of stem or progenitor cells to a joint to enhance recovery from joint surgery
US9192695B2 (en) 2008-11-20 2015-11-24 Allosource Allografts combined with tissue derived stem cells for bone healing
JP2012510874A (ja) 2008-12-05 2012-05-17 リジェネレイティブ サイエンシーズ, エルエルシー 無血管組織の修復を促進するための方法及び組成物
WO2010099463A2 (en) 2009-02-27 2010-09-02 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Joint bioscaffolds
IT1394570B1 (it) * 2009-07-02 2012-07-05 Fidia Farmaceutici Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.
WO2011047058A2 (en) * 2009-10-13 2011-04-21 Allocure Inc. Assay for the prediction of therapeutic effectiveness of mesenchymal stromal cells, and methods of using same
US9113950B2 (en) 2009-11-04 2015-08-25 Regenerative Sciences, Llc Therapeutic delivery device
CN103180435A (zh) * 2010-08-31 2013-06-26 库克通用生物技术有限责任公司 用于治疗动物疾病的全身的同种异体干细胞疗法
US20120087933A1 (en) 2010-10-08 2012-04-12 Samson Tom Enhanced msc preparations
US8709401B2 (en) 2011-02-25 2014-04-29 Howmedica Osteonics Corp. Primed stem cells and uses thereof to treat inflammatory conditions in joints
US9133438B2 (en) 2011-06-29 2015-09-15 Biorestorative Therapies, Inc. Brown fat cell compositions and methods
GB201202319D0 (en) 2012-02-10 2012-03-28 Orbsen Therapeutics Ltd Stromal stem cells
US9457051B2 (en) * 2013-01-22 2016-10-04 Animal Cell Therapies, Inc. Use of stem cells or progenitor cells to treat, delay, prevent, or repair tearing of cruciate ligaments
US10272118B2 (en) 2013-02-12 2019-04-30 Replicel Life Sciences Inc. Compositions and methods for treating and repairing tendons
CA2894750C (en) 2013-02-22 2021-12-14 Allosource Cartilage mosaic compositions and methods
CA2895140C (en) 2013-03-15 2021-07-13 Allosource Perforated osteochondral allograft compositions
WO2014150784A1 (en) 2013-03-15 2014-09-25 Allosource Cell repopulated collagen matrix for soft tissue repair and regeneration
US20150010606A1 (en) * 2013-07-08 2015-01-08 Arthrex, Inc. Intra-articular injection and implant attachment of molecule consisting of lubricin and extracellular superoxide dismutase or hyaluronic acid and extracellular superoxide dismutase
US9597099B2 (en) * 2013-07-29 2017-03-21 Covidien Lp Energy-based treatment methods for refractory gout
EP3028722B1 (en) 2013-08-01 2018-11-28 TWO CELLS Co., Ltd. Cartilage-damage treatment agent and method for producing same
MX2016009867A (es) 2014-01-28 2017-01-11 Medivation Technologies Inc Terapias dirigidas.
EP3074506A1 (en) 2014-02-12 2016-10-05 National University of Ireland, Galway Selection and use of stem cells
US10500233B2 (en) * 2014-02-12 2019-12-10 Replicel Life Sciences Inc. Compositions and methods for treating bone, joints and cartilage
RU2559089C1 (ru) * 2014-04-22 2015-08-10 Государственное автономное учреждение здравоохранения "Республиканская клиническая больница Министерства здравоохранения Республики Татарстан" Способ восстановления дефектов гиалинового хряща суставных поверхностей суставов конечностей
EP3209768A1 (en) 2014-07-25 2017-08-30 Recellerate Inc. Methods of treating exercise-induced pulmonary hemorrhage
TWI566774B (zh) 2014-10-06 2017-01-21 佛教慈濟醫療財團法人花蓮慈濟醫院 治療關節疾病的組成物及其方法
RU2644650C2 (ru) 2014-12-01 2018-02-13 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток и способ его получения
WO2017019832A1 (en) 2015-07-29 2017-02-02 Medivation Technologies, Inc. Methods and compositions using repair cells and cationic dyes
KR101720329B1 (ko) 2015-12-11 2017-03-28 주식회사 에이티앤씨 무선통신 단말기용 nfc 및 mst 공용 안테나 장치
RU2708329C2 (ru) 2016-05-31 2019-12-05 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток, композиции и способы применения
CN106075585B (zh) * 2016-07-08 2019-06-21 福建师范大学 一种基于人工肌腱支架材料的组织工程化人工肌腱移植物的制备方法
US20190247439A1 (en) * 2016-10-07 2019-08-15 Cytori Therapetics, Inc. Regenerative cell therapy for musculoskeletal disorders
US9980984B2 (en) 2016-10-13 2018-05-29 Kenneth Allen Pettine Treatment of inflammation of osteoarthritic knees with mesenchymal stem cells
WO2018092769A1 (ja) 2016-11-15 2018-05-24 株式会社カネカ 胎児付属物に由来する間葉系幹細胞を含む細胞集団とその製造方法、及び医薬組成物
CN110234329A (zh) * 2017-01-27 2019-09-13 辛特拉股份公司 骨骼和软骨损害或疾病的预防和治疗
AU2018372631B2 (en) 2017-11-22 2025-06-05 Mesoblast International Sarl Cellular compositions and methods of treatment I
JP7454379B2 (ja) 2017-12-28 2024-03-22 株式会社カネカ 接着性幹細胞を含む細胞集団とその製造方法、及び医薬組成物
US20210047621A1 (en) 2018-03-12 2021-02-18 Universidade Do Porto Compositions for use in the treatment of musculoskeletal conditions and methods for producing the same leveraging the synergistic activity of two different types of mesenchymal stromal/stem cells
JP7530893B2 (ja) 2019-06-14 2024-08-08 株式会社カネカ 間葉系細胞を含む細胞集団、それを含む医薬組成物、及び、その製造方法
US11583402B2 (en) 2019-07-16 2023-02-21 William Baumgartl Method for treating joint pain
CA3149572A1 (en) * 2019-08-30 2021-03-04 Ashlee WATTS Xenogen-free mesenchymal stem cell compositions and methods of use
US20220290105A1 (en) * 2019-11-26 2022-09-15 Cells For Cells S.A. Mesenchymal stem cells with enhanced therapeutic properties
WO2021226373A2 (en) 2020-05-08 2021-11-11 Gallant Pet, Inc. Uterine-derived regenerative cell compositions and uses thereof
US12278085B2 (en) 2022-04-06 2025-04-15 Applied Materials Israel Ltd. Hybrid scanning electron microscopy and acousto-optic based metrology
WO2025076042A1 (en) * 2023-10-02 2025-04-10 MAM Holdings of West Florida, L.L.C. Mesenchymal stem cell-mediated treatments for the prevention and targeted treatment of injured tissues and promotion of tissue repair, healing, and regeneration
CN120866212B (zh) * 2025-09-28 2026-02-24 山东省泉溪生物技术有限公司 一种用于膝关节炎治疗的羊膜间充质干细胞及其制备方法与应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68218A (en) * 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
US5053050A (en) * 1988-04-29 1991-10-01 Samuel Itay Compositions for repair of cartilage and bone
US5399493A (en) * 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
FR2667788B1 (fr) * 1990-10-12 1994-12-02 Oreal Utilisation d'hydroxyalkylamino-9,10-anthraquinones pour la teinture de fibres keratiniques humaines, composition cosmetique les contenant en association avec des colorants azouiques et nitres.
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5326357A (en) * 1992-03-18 1994-07-05 Mount Sinai Hospital Corporation Reconstituted cartridge tissue
US5736396A (en) * 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5906934A (en) * 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
US5716616A (en) * 1995-03-28 1998-02-10 Thomas Jefferson University Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects
ATE288480T1 (de) * 1995-11-16 2005-02-15 Univ Case Western Reserve Chondrogene in vitro induktion von menschlichen mensenchymalen stammzellen
US6482231B1 (en) * 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
DK2111876T3 (da) * 1995-12-18 2011-12-12 Angiodevice Internat Gmbh Tværbundne polymerpræparater og fremgangsmåder til anvendelse deraf
US6200606B1 (en) * 1996-01-16 2001-03-13 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration
US5842477A (en) * 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
WO1998051317A1 (en) * 1997-05-13 1998-11-19 Osiris Therapeutics, Inc. Osteoarthritis cartilage regeneration using human mesenchymal stem cells
CA2212300A1 (en) * 1997-08-04 1999-02-04 Abdellatif Chenite In vitro or in vivo gelfying chitosan and therapeutic uses thereof
US6082364A (en) * 1997-12-15 2000-07-04 Musculoskeletal Development Enterprises, Llc Pluripotential bone marrow cell line and methods of using the same
PT1062321E (pt) * 1998-03-13 2005-05-31 Osiris Therapeutics Inc Utilizacoes para celulas estaminais mesenquimais humanas nao autologas
IT1299488B1 (it) * 1998-06-01 2000-03-16 Afatec S R L Tubo corrugato bimetallico e procedimento per la sua realizzazione
EP1154734B1 (en) * 1999-02-12 2014-10-01 ProChon Biotech Ltd. Injectable collagen-based system for delivery of cells
US6716616B1 (en) * 1999-09-28 2004-04-06 Lexicon Genetics Incorporated Human kinase proteins and polynucleotides encoding the same
DE60143517D1 (de) * 2000-04-25 2011-01-05 Osiris Therapeutics Inc Wiederherstellung der gelenken mit mesenchymalen stammzellen

Similar Documents

Publication Publication Date Title
JP2016216487A5 (enExample)
Qazi et al. Corneal transparency: genesis, maintenance and dysfunction
ES2572211T3 (es) Regeneración de músculo esquelético utilizando células madre mesenquimales
AU2015287920A8 (en) Micronized Wharton's Jelly
CL2009000498A1 (es) Compuestos derivados de benzo [f][1,7]naftiridin sustituidos, moduladores de receptor toll; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedad infecciosa, inflamatoria, dermatologica, respiratoria o inmune.
BR112013013950A2 (pt) antagonista de lpa1 policíclico e usos dos mesmos
JP2004507454A5 (ja) 動物の関節修復のための医薬組成物調製への間葉幹細胞の使用法
UA99152C2 (ru) Восстановление и регенерация почечной ткани с использованием клеток, полученных с человеческой ткани пупочного канатика
JP2017517255A5 (enExample)
MX2018015032A (es) Composicion y metodo para reparacion y regeneracion muscular.
CA2747794A1 (en) Treatment of lung and pulmonary diseases and disorders
WO2015009991A8 (en) Methods, systems, and compositions for promoting bone growth
HRP20160646T1 (hr) Poboljšano liječenje multiplog mijeloma
WO2009048778A3 (en) Laminins, derivatives, and compositions including same and method for their therapeutic use
EA200900211A1 (ru) Замещенные производные имидазолона, их получение и применение
WO2010134007A3 (en) Low-level energy laser therapy
PH12013500923A1 (en) Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative
WO2010082787A3 (ko) 연골줄기세포를 유효성분으로 포함하는 골질환 치료용 또는 항염증용 약제학적 조성물
HK1258825A1 (zh) 用於治疗多汗症的方法和组合物
MX2010009395A (es) Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y procesos para preparacion de los mismos.
HRP20220700T1 (hr) Vezikularne formulacije za uporabu u liječenju boli ili smanjene pokretljivosti zgloba
WO2014165723A3 (en) Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells
RU2016137289A (ru) Схема применения соединения fgf-18
RU2014138500A (ru) Клеточный препарат, включающий жировые клетки
WO2019210320A3 (en) Methods and compositions to stimulate retinal regeneration